Intra-Cellular Therapeutics

Intra-Cellular roars back on success in bipolar depression
BioPharma Dive
Wed, 09/9/20 - 08:07 pm
Intra-Cellular Therapeutics
bipolar disorder
lumateperone
clinical trials
Before 2019 closes, the FDA has 3 key approval decisions to make
Biopharma Dive
Wed, 11/27/19 - 12:43 pm
Allergan
ubrogepant
migraines
Amarin
Vascepa
Intra-Cellular Therapeutics
lumateperone
schizophrenia
bipolar disorder
drug approvals
FDA